KLF10
KLF10 is a nuclear C2H2-type zinc-finger transcriptional repressor that acts as an effector of transforming growth factor beta signalling. It is also known as TIEG1, TIEG and EGRA, reflecting its original description as a TGFB inducible early growth response gene. Browse Assay Genie's current range of KLF10 research reagents below, or read on for the biology behind the target.
KLF10 is a transcriptional repressor that binds the consensus sequence 5'-GGTGTG-3'. It contributes to regulation of the circadian clock: it binds the GC box sequence in the promoter of the core clock component ARTNL/BMAL1 and represses its transcriptional activity. In the liver, KLF10 regulates the circadian expression of genes involved in lipogenesis, gluconeogenesis and glycolysis, and it represses expression of PCK2, an enzyme that catalyses a rate-limiting step of gluconeogenesis. It may also play a role in cell cycle regulation.
The KLF10 gene encodes a member of a family of proteins that feature C2H2-type zinc finger domains. The protein belongs to the Sp1 C2H2-type zinc-finger protein family and is classified by HGNC within the zinc fingers C2H2-type group and the KLF transcription factors. Alternative splicing of the KLF10 gene results in multiple transcript variants. The mouse and rat orthologs are both named Klf10.
The earlier names of this protein, TGFB inducible early growth response and Kruppel like factor 10, describe its connection to transforming growth factor beta signalling, for which it acts as an effector. According to the NCBI Gene summary, KLF10 activity may inhibit the growth of cancers, particularly pancreatic cancer, which makes it a point of interest in cancer biology alongside its roles in circadian and metabolic control.
KLF10 represses ARTNL/BMAL1 transcription through its promoter GC box, linking it to the core circadian clock machinery.
KLF10 regulates circadian expression of lipogenic, gluconeogenic and glycolytic genes in the liver and represses PCK2.
KLF10 is a transcriptional repressor that acts as an effector of transforming growth factor beta signalling.
KLF10 activity may inhibit the growth of cancers, particularly pancreatic cancer, and the protein may also contribute to cell cycle regulation.
KLF10 is a nuclear transcriptional repressor that binds the sequence 5'-GGTGTG-3'. It represses ARTNL/BMAL1 to help regulate the circadian clock, controls circadian expression of hepatic lipogenic, gluconeogenic and glycolytic genes, represses PCK2, and may play a role in cell cycle regulation.
KLF10 is also called TIEG1, TIEG and EGRA. Previous names include TGFB inducible early growth response and Kruppel like factor 10. UniProt lists the protein as Krueppel-like factor 10. Alternative splicing of the gene produces multiple transcript variants.
Mouse and rat both have a Klf10 ortholog, so the gene is present across these common model species; check the datasheet of any product for its validated reactivity. NCBI notes that KLF10 activity may inhibit cancer growth, particularly pancreatic cancer.
Other KLF transcription factors and C2H2-type zinc-finger proteins with research reagents at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13118; product specifications from Assay Genie datasheets.